Training future researchers in cell signaling and regulation related to Down syndrome
Predoctoral Training in Signaling in Cellular Regulation (T32) INCLUDE Down Syndrome Supplement
This program is designed to help students learn about cell signaling and regulation, especially in relation to Down syndrome, by providing hands-on training and mentorship at the University of Colorado, Boulder, while also promoting diversity in research.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-11094478 on NIH RePORTER |
What this research studies
This program focuses on training predoctoral students in the field of cell signaling and regulation, particularly as it relates to conditions like Down syndrome. Students will work with experienced mentors at the University of Colorado, Boulder, learning about key biological pathways and how to conduct rigorous scientific research. The training includes a mix of coursework, seminars, and collaborative research opportunities, aimed at developing critical thinking and problem-solving skills in molecular biosciences. Participants will also engage in community efforts to support diversity in the research field.
Who could benefit from this research
Good fit: Ideal candidates for participation would include predoctoral students interested in cell biology and signaling, particularly those focusing on Down syndrome.
Not a fit: Patients not pursuing a career in research or those not affected by conditions related to cellular signaling may not benefit from this program.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for conditions related to Down syndrome and other cellular regulation disorders.
How similar studies have performed: Similar training programs have successfully produced skilled researchers in the field, contributing to advancements in understanding cellular mechanisms.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Ahn, Natalie G. — University of Colorado
- Study coordinator: Ahn, Natalie G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.